Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 14, 2025 • 1:00 AM ET
As of June 14, 2025 • 1:00 AM ET
Date/Time | Source | News Release |
---|---|---|
05/13/2025 07:47 AM EDT | SeekingAlpha | Minerva Neurosciences GAAP EPS of -$0.50 |
05/07/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Wednesday, May 7th, 2025 |
05/07/2025 05:31 AM EDT | US Earnings Reports | Expected earnings - Minerva Neurosciences Inc |
02/26/2025 04:31 AM EST | US Earnings Reports | Expected earnings - Minerva Neurosciences Inc |
02/25/2025 07:44 AM EST | SeekingAlpha | Minerva Neurosciences GAAP EPS of -$0.56 |
11/27/2024 04:31 AM EST | US Earnings Reports | Expected earnings - Minerva Neurosciences Inc |
11/05/2024 07:37 AM EST | SeekingAlpha | Minerva Neurosciences GAAP EPS of $2.97 |
08/06/2024 07:43 AM EDT | SeekingAlpha | Minerva Neurosciences GAAP EPS of -$1.09 |
07/03/2024 02:25 PM EDT | Zacks | Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates |
07/03/2024 08:06 AM EDT | Zacks | Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.